These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 2178539

  • 21. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Ferrandina G, Macchia G, Legge F, Deodato F, Forni F, Digesù C, Carone V, Morganti AG, Scambia G.
    Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
    [Abstract] [Full Text] [Related]

  • 22. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y, Liang LZ, Zheng M, Wei M, Shen Y.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [Abstract] [Full Text] [Related]

  • 23. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 24. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
    Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ.
    J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
    [Abstract] [Full Text] [Related]

  • 25. Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma.
    Nabeya Y, Shimada H, Okazumi S, Matsubara H, Gunji Y, Suzuki T, Ochiai T.
    Cancer; 2002 Feb 15; 94(4):940-9. PubMed ID: 11920462
    [Abstract] [Full Text] [Related]

  • 26. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
    Ohno T, Nakayama Y, Nakamoto S, Kato S, Imai R, Nonaka T, Ishikawa H, Harashima K, Suzuki Y.
    Cancer; 2003 Jun 15; 97(12):3114-20. PubMed ID: 12784349
    [Abstract] [Full Text] [Related]

  • 27. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A, Tana R, Cosio S, Genazzani AR.
    Crit Rev Oncol Hematol; 2008 Apr 15; 66(1):10-20. PubMed ID: 17964182
    [Abstract] [Full Text] [Related]

  • 28. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer.
    Takeshima N, Hirai Y, Katase K, Yano K, Yamauchi K, Hasumi K.
    Gynecol Oncol; 1998 Mar 15; 68(3):263-6. PubMed ID: 9570978
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
    Ikeda K, Terashima M, Ishida K, Okamoto K, Suzuki S, Murakami K, Ohtsu T, Suzuki K, Niitsu Y, Obonai H.
    Gan To Kagaku Ryoho; 1988 Apr 15; 15(4 Pt 1):677-82. PubMed ID: 3355186
    [Abstract] [Full Text] [Related]

  • 38. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O, Bruns F, Schäfer U, Prott FJ, Willich N.
    Anticancer Res; 2005 Apr 15; 25(3A):1663-6. PubMed ID: 16033078
    [Abstract] [Full Text] [Related]

  • 39. [Study of the squamous cell carcinoma (SCC) antigen in benign diseases].
    Gris JM, Xercavins J, Trillo L, Encabo G.
    Med Clin (Barc); 1996 Feb 17; 106(6):205-8. PubMed ID: 8667660
    [Abstract] [Full Text] [Related]

  • 40. Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA 125 determinations.
    Massuger LF, Koper NP, Thomas CM, Dom KE, Schijf CP.
    Gynecol Oncol; 1997 Mar 17; 64(3):473-6. PubMed ID: 9062153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.